We observed that tear VEGF levels in progressing stage1 ROP were significantly lower compared to control, progressing stage 2, stage 3 ROP, and Group-2A AROP (Fig. 2A, Supplementary Table 2). This evidence concerns the gene VEGFA and retinopathy of prematurity.